In June 2017, Bristol-Myers Squibb presented the clinical trial data of its Phase 1/2 ECHO-204 trial.
In 2Q17, Bristol-Myers Squibb’s (BMY) Opdivo generated revenues of around $1.2 billion, which reflected ~45% growth on a year-over-year basis.
In 2Q17, Bristol-Myers Squibb reported diluted earnings per share (or EPS) of $0.56 compared to $0.69 in 2Q16.
Of the 23 analysts covering Bristol-Myers Squibb (BMY) in August 2017, six analysts recommended a “strong buy,” and four analysts recommended a “buy.” Ten analysts recommended a “hold,” and three analysts recommended a “sell.”
The online streaming segment is getting more competitive by the day. First, Netflix (NFLX) purchased Millarworld, a comic book publisher, earlier this month, to help develop its own programming. Last week, Amazon…
On August 15, Amazon (AMZN) sold $16 billion in bonds to fund its acquisition of Whole Foods (WFM). The bonds were met with robust demand from investors, as the tech giant rarely…
Tencent Holdings (TCEHY), China’s biggest gaming and social media company by revenue, reported its fiscal 2Q17 results on Wednesday, August 16. The Shenzhen-based company beat forecasts and reported its best-ever quarterly…
The tech and media sector has seen major developments recently, including some exciting partnerships and acquisitions. Let’s look at what’s to come.
Freeport-McMoRan (FCX) is expected to post adjusted EBITDA (earnings before interest, tax, depreciation, and amortization) of $4.9 billion this year and $6.3 billion next year.
Freeport-McMoRan (FCX) closed at $14.77 on August 16, gaining 5.7% from its previous close. The stock has been consolidating over the last few trading sessions.
Bank of America reported deposits totaling ~$1.3 trillion in 2Q17, compared to ~$1.2 trillion in 2Q16.
The Trump administration has proposed the Financial CHOICE Act, which aims to reverse or amend regulations set forth by Dodd-Frank.
Of the 30 analysts covering Bank of America, 22 analysts (~73%) gave it “buy” or “strong buy” ratings in August 2017.
JPMorgan Chase (JPM) returned $4.5 billion to shareholders in 2Q17 for a payout ratio of 64%.
In 2Q17, Bank of America’s expenses stood at ~$13.7 billion, representing a sequential decline.
In 2Q17, BAC generated ROA (return on assets) of 0.93%, which was higher than its ROA of 0.88% in 1Q17.
JPMorgan Chase (JPM) stock has generated a return of 3.9% over the last six months and 41.6% over the past year, reflecting high growth and stable performance.
JPMorgan Chase (JPM) witnessed the strongest growth in loans and deposits of 9% and 10%, respectively, among the major banks.
Bank of America’s (BAC) Global Banking division posted net income of ~$1.8 billion in 2Q17, compared to $1.7 billion in 1Q17 and $1.5 billion in 2Q16.
Bank of America’s (BAC) Global Wealth and Investment division posted net income of $804.0 million in 2Q17, up 14.0% on a year-over-year basis.